DIRS.INFO The most relevant business & tech news

☆ Stock spinoffs beat the market by 10%. Here are some recent ones to buy
▼ + stars: | 2023-07-18 | by ( Michelle Fox | ) www.cnbc.com time to read: +2 min

Investors looking for some outperformance may want to check out stocks that are spun off from their parent companies, according to Morgan Stanley. Two years after completion, spinoffs outperformed the market by an average of 10.2%, the investment bank found. Parent companies, on the other hand, underperformed by 8%. "Spinoffs present investors with a unique opportunity to capitalize on unlocked and potentially underappreciated value," analyst Todd Castagno wrote in a note Monday. One of the biggest spinoffs in the past year was GE Healthcare Technologies , which split from General Electric in December.

Persons: Morgan Stanley, Todd Castagno, — Michael Bloom Organizations: BorgWarner, New York Stock Exchange, Nasdaq, GE Healthcare Technologies, General Electric, GE Health Locations: LabCorp

☆ The market is undervaluing this stock — so we're adding to our position
▼ + stars: | 2023-07-18 | by ( Jeff Marks | ) www.cnbc.com time to read: +2 min

As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio. If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . A GE Healthcare Ltd. BioProcess machine stands on display during the International Pharmaceutical Expo (Interphex) in New York.

Persons: Jim Cramer's, GEHC, Jim Cramer, Jim Organizations: GE Healthcare Technologies, GEHC, Medicare, GE Healthcare, Alzheimer's, CNBC, GE Healthcare Ltd, International Pharmaceutical, Bloomberg, Getty Locations: New York

☆ Moderna strikes deal to develop mRNA drugs in China
▼ + stars: | 2023-07-05 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +2 min

Moderna on Wednesday said it struck a deal with Chinese officials to research, develop and manufacture messenger RNA medicines in the country, despite rising tensions between the U.S. and China. The Massachusetts-based biotech company signed a memorandum of understanding and a related land collaboration deal to develop drugs that will "be exclusively for the Chinese people" and won't "be exported," a Moderna spokesperson told CNBC. The Moderna spokesperson did not confirm the report or comment on the size of the deal. Moderna in May said it was keen to sell its mRNA Covid vaccine to China after registering a legal entity in the world's second-largest economy. The country has also struggled to develop mRNA technology at home during the pandemic.

Persons: Stéphane Bancel, It's, drugmakers, Biden Organizations: Moderna, U.S, CNBC, The Moderna, Pfizer, China's Ministry of Commerce, AstraZeneca, Novo Nordisk, Merck, Sanofi, GE HealthCare Technologies Locations: China, The Massachusetts, Shanghai, Japan, Canada, Australia, Kenya, Beijing, New York

NEW YORK/LONDON, June 30 (Reuters) - A lackluster IPO market is showing signs of life as a flurry of deals in the United States and Europe raise hopes that a recovery may be in sight. With investors now predicting an end to the Federal Reserve's rate hikes later this year, optimism has resumed. This allowed thrift shop chain Savers Value Village (SVV.N) to raise $401 million in its New York IPO this week, more than it originally set out to. Investors continued to snap up its shares, with the stock closing up 27% on its first day of trading. EUROPE IPOS ON THE WAYIn Europe, three IPOs are on track to be completed by early July, but two of them have already had to moderate their valuation expectations.

Persons: Aloke Gupte, Tom Swerling, Paul Abrahimzadeh, Hidroelectrica, Fondul, WE Soda, Ferretti, Coty, Andrew Briscoe, David DiPietro, Rowe Price, Echo Wang, Pablo Mayo, Elisa Martinuzzi, Mark Potter Organizations: Investors, JPMorgan Chase &, CAB, Kodiak Gas Services, Fidelis Insurance Holdings, Barclays, North America, Citigroup, U.S, Heineken, General, GE Healthcare Technologies, Bank of, Pablo Mayo Cerquiero, Thomson Locations: United States, Europe, Ukraine, New York, London, Africa, Asia, Kodiak, Fidelis, Cava, EUROPE, Romanian, Hong Kong, Milan, East

This spike bodes well for the IPO market, bankers say, because both new listings and secondary stock sales rely on strong demand from equity investors. "Historically, follow-on activity of this magnitude should lead to animal spirits in the IPO market," said Daniel Burton-Morgan, head of Americas syndicate for equity capital markets at Bank of America Corp (BAC.N). The IPO market has been in the doldrums since the start of 2022, when Russia's invasion of Ukraine and a spike in inflation fueled a bout of market volatility as investors fretted over U.S. interest rate hikes. The week of June 5 saw 19 follow-on and secondary stock sales in the United States, totaling proceeds of $6.6 billion, one of the highest weekly tallies since the end of 2021. IPO HOPEFULSMajor companies are waiting in the wings to launch their market debut come September, when the IPO window traditionally opens after a summer lull.

Persons: Daniel Burton, Morgan, Goldman Sachs, Electric's, Alex Wellins, Keith Townsend, Echo Wang, Lance Tupper, Greg Roumeliotis, Sam Holmes Organizations: YORK, LSEG, Intelligence, Bank of America Corp, Dealogic, Reuters Graphics, Federal, Goldman, Intel Corp, GE Healthcare Technologies, SoftBank Group Corp, chipmaker, Holdings, Blueshirt, King, Spalding, Thomson Locations: United States, Ukraine, Cava, New York

Shortly after the opening bell Wednesday, we'll be buying 15 shares of Humana (HUM), at roughly $473 apiece. Following the trade, Jim Cramer's Charitable Trust will own 100 shares of HUM, increasing its weighting in the portfolio to 1.83%, from 1.56%. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: we'll, Jim Cramer's, Johnson, UNH, Jim Cramer, Jim, Owen Franken Organizations: Humana, Johnson, GE Healthcare Technologies, UnitedHealth, CNBC

☆ General Electric to sell over $2 bln stake in GE HealthCare
▼ + stars: | 2023-06-05 | by ( ) www.reuters.com time to read: 1 min

June 5 (Reuters) - General Electric Co (GE.N) is offering 25 million of common stock, or over a $2 billion stake, in GE HealthCare Technologies Inc (GEHC.O), according to a regulatory filing on Monday. Reporting by Raghav Mahobe in Bengaluru; Editing by Maju SamuelOur Standards: The Thomson Reuters Trust Principles.

Persons: Raghav, Maju Samuel Organizations: General Electric Co, GE HealthCare Technologies Inc, Thomson Locations: Bengaluru

☆ 'If it gets hit, we'll buy more,' Jim Cramer says of this cybersecurity firm
▼ + stars: | 2023-05-18 | by ( Christopher Alessi | In | ) www.cnbc.com time to read: +3 min

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. Stick with Palo Alto Networks Shares of Club holding Palo Alto Networks (PANW) came under pressure Thursday, as investors fled the cybersecurity name over growing recession fears. Morgan Stanley maintained an overweight, or buy, rating on Palo Alto stock, with a price target of $255 per share. Watch Meta Platforms Shares of Meta Platforms (META) initially edged up Thursday on news Montana will become the first U.S. state to ban competitor TikTok . As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade.

The insurance company posted 84 cents in adjusted earnings per share and $1.11 billion in revenue. However, the company's $592.2 million quarterly revenue fell below the $593.9 million anticipated by Wall Street. Although the company's quarterly adjusted earnings and revenue topped analysts' expectations, investors may have been disappointed in its muted full-year outlook. Danaher's GAAP operating profit of $1.79 billion fell below analysts' estimates of $2.12 billion, according to FactSet. General Motors — Shares fell 3.3% after the automaker lowered its guidance for net income attributable to stockholders in 2023.

☆ Exclusive: ICU Medical to compete against GE Healthcare for Medtronic units -sources
▼ + stars: | 2023-03-29 | by ( David Carnevali | ) www.reuters.com time to read: +2 min

GE Healthcare and private equity firms Carlyle Group Inc (CG.O) and Clayton, Dubilier & Rice (CD&R), which have been pursuing rival offers separately, are also through to the second round, the sources added. Carlyle is bidding through its newly formed healthcare investment platform Atmas Health, according to one of the sources. Medtronic has been taking offers for its patient monitoring and respiratory interventions businesses even as it presses on with preparations to spin them off to its shareholders. ICU Medical, GE Healthcare, Carlyle and CD&R declined to comment. The patient monitoring technology portfolio includes Nellcor pulse oximetry and BIS brain monitoring, while the respiratory interventions business comprises ventilators and breathing systems.

☆ GE HealthCare Makes Push Into Artificial Intelligence
▼ + stars: | 2023-02-16 | by ( Melanie Evans | ) www.wsj.com time to read: 1 min

GE HealthCare hopes to tap into machine learning to help hospitals diagnose patients and assign beds, among other tasks. GE HealthCare Technologies Inc. is making a big bet on an important challenge in healthcare: collecting the disparate data on patients generated by machines and medical records and making it useful to hospitals. In pursuing a software platform that can help hospitals do things like find open beds and identify patients at risk for sepsis, GE HealthCare is taking on tech powerhouses such as Alphabet Inc.’s Google, Amazon.com Inc. and Microsoft Corp., which are already selling such services and bring the big-data and artificial-intelligence expertise the technology requires.

☆ GE’s Finance Chief Sees Future for AI Across Company’s Business
▼ + stars: | 2023-02-08 | by ( Thomas Gryta | ) www.wsj.com time to read: +3 min

General Electric Co. sees a future for using generative artificial intelligence like ChatGPT across its business, from the shop floor to the front office, according to Carolina Dybeck Happe, the company’s chief financial officer. Ms. Dybeck Happe said the use of AI in manufacturing begins with gathering a huge amount of data from different complex systems. A native of Sweden, she joined GE after spending about a year as finance chief of Denmark-based shipping giant A.P. She became GE’s finance chief in early 2020, taking on a role traditionally held by long-term employees of the company, which has long prided itself on its management training. Using artificial intelligence and automation is part of increasing efficiency and quality, Ms. Dybeck Happe said.

☆ As ChatGPT mania takes hold, here's how companies beyond tech are using A.I.
▼ + stars: | 2023-02-08 | by ( Samantha Subin | ) www.cnbc.com time to read: +7 min

AI's been in use for years, of course, helping companies improve products, efficiency and their business models. Media conglomerate Comcast (the parent of CNBC) is harnessing AI to improve expenses and innovate within high-speed broadband, while Stanley Black & Decker mentioned it's using AI to help customers better measure the hardening of concrete. Here's how some of the biggest companies outside of technology are utilizing AI to improve their businesses: Healthcare companies bet on AI One of the biggest beneficiaries of the latest AI trends might be healthcare companies. Some health companies also view machine learning and AI as tools to assist in areas with doctor shortages or fewer resources. Minneapolis-based utility Xcel Energy said it's using AI technology to improve efficiency at its plants and move from "reactive to proactive maintenance," said Brian Van Abel, Xcel's chief financial officer.

☆ Cramer's lightning round: Stick with Netflix
▼ + stars: | 2023-02-02 | by ( Krystal Hur | ) www.cnbc.com time to read: 1 min

Stick with it." Loading chart...GE Healthcare Technologies Inc : "I like the stock. I say, stay along." Loading chart...DraftKings Inc : "Stock could come around, but it's got to be 50 states before we get there." Loading chart...Medtronic PLC : "Medtronic right now is not being run well.

☆ Stocks making the biggest moves midday: Carvana, Colgate-Palmolive, Tesla and more
▼ + stars: | 2023-01-30 | by ( Pia Singh | ) www.cnbc.com time to read: +2 min

Tesla — Shares dropped 2.8% after Berenberg lowered its earnings estimate for Tesla by around 25% for 2023 following the company's price cuts for its electric vehicles. Ford Motor Company — Shares fell nearly 1.4% after the company announced price cuts for its electric Mustang Mach-E crossover. The move in Ford comes after Tesla said earlier this month it would trim prices to counteract dwindling demand. AMC Entertainment — Common shares of the theater chain fell by more than 7% after AMC announced a shareholder meeting in March for a potential change to its capital structure. The preferred or "APE" shares, which trade at a large discount to the common shares, jumped by more than 16%.

☆ This week's best performers include two airlines and a media stock expected to rally 48%
▼ + stars: | 2023-01-13 | by ( Michelle Fox | ) www.cnbc.com time to read: +3 min

United Airlines has 5% upside to the average analyst price target and its stock is rated a buy by 48% of the analysts covering it. However, American Airlines average price target implies 4% downside and just 9% of the analysts covering it have a buy rating. Discovery to rally almost 49%, according to the average price target. The media company, which gained 16% this week, is rated a buy by 46% of the analysts covering the stock. Meanwhile, Royal Caribbean has 6% upside to the average price target and a buy rating from 42% of the analysts covering the stock.

☆ GE HealthCare expects organic revenue growth of 5%-7% in 2023
▼ + stars: | 2023-01-10 | by ( ) www.reuters.com time to read: 1 min

Jan 10 (Reuters) - GE HealthCare Technologies Inc (GEHC.O) expects 2023 organic revenue growth to be in the range of 5% to 7%, the company said on Tuesday, citing robust customer demand, fulfillment of older orders, and improved pricing. The forecast is in line with the company's medium-term target of mid-single-digit organic revenue growth that it gave last month. "While inflation remains a factor, we are seeing the supply chain environment continue to improve with demand for our products and services growing in 2023," Chief Executive Officer Peter Arduini said in a statement. GE HealthCare had garnered about $18.3 billion in revenue last year, according to preliminary data, with a 7% organic growth. Reporting by Leroy Leo in Bengaluru; Editing by Shounak Dasgupta and Subhranshu SahuOur Standards: The Thomson Reuters Trust Principles.

☆ Stocks making the biggest moves midday: Silvergate, Bed Bath & Beyond, Walgreens and more
▼ + stars: | 2023-01-05 | by ( Tanaya Macheel | ) www.cnbc.com time to read: +3 min

Silvergate — Shares of the crypto-focused bank tumbled more than 42% after Silvergate disclosed massive customer withdrawals during the fourth quarter. Bed Bath & Beyond — The home goods retailer plummeted 24% after reporting it's running out of cash and is considering bankruptcy, citing weaker-than-expected sales. Constellation Brands — The alcoholic beverage maker's shares fell 8.8% after quarterly earnings came in slightly lower than analysts expected, according to FactSet. The food company reported earnings of 81 cents per share on revenue of $3.31 billion in revenue. GE Healthcare Technologies — Shares of the new public company fell 3% on their second day of trading, after rallying 8% on Wednesday.

☆ Jim Cramer's top 10 things to watch in the market Wednesday: Tech layoffs, bank double downgrade, opportunities in industrials
▼ + stars: | 2023-01-04 | by ( Jim Cramer | ) www.cnbc.com time to read: +4 min

Analysts lower their rating on the tech giant to neutral from buy and their price target to $250 per share from $300. Analysts also cut price target to $100 per share from $118. Analysts trim price target to $193 per share from $220. BofA raises Merck (MRK) rating to buy from neutral and price target to $130 per share from $110. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade.

☆ J&J's consumer health unit Kenvue files for IPO, moving closer to spin-off
▼ + stars: | 2023-01-04 | by ( ) www.reuters.com time to read: +2 min

Jan 4 (Reuters) - Johnson & Johnson's (JNJ.N) consumer health unit Kenvue on Wednesday filed to be listed as an independent company, bringing the healthcare conglomerate a step closer to completing the biggest shakeup in its 135-year history. The filing, for Kenvue to list on the New York Stock Exchange under the ticker symbol "KVUE", comes more than a year after Johnson & Johnson announced its plan to break up into two companies. J&J's pharmaceutical and medical equipment units, which make cancer treatments and surgical tools, had recorded nearly $80 billion in sales in 2021, far ahead of its consumer products revenues. General Electric's (GE.N) spun-off healthcare unit, GE HealthCare Technologies , debuted as an independent company on Nasdaq on Wednesday. Kenvue said J&J will continue to own at least 80.1% of the voting power of the company's shares upon completion of the offering.

☆ GE HealthCare shares rise in market debut
▼ + stars: | 2023-01-04 | by ( ) www.reuters.com time to read: +1 min

Jan 4 (Reuters) - Shares of GE HealthCare Technologies Inc reversed course to trade up 4.4% in their market debut on Wednesday, after the medical equipment maker completed its separation from industrial conglomerate General Electric Co (GE.N). GE said in 2021 it would split into three public companies to simplify its business, pare down debt and breathe life into battered shares. GE HealthCare - which will operate imaging and ultrasound devices, patient care solutions and pharmaceutical diagnostics businesses - expects its addressable markets will expand to $102 billion by 2025 from $84 billion in 2021. The company will be present in more than 160 countries and have about 51,000 employees worldwide, GE HealthCare said on Wednesday. Shares of the company, which is scheduled to release its fourth-quarter and full-year results on Jan. 30, were trading at $58.40 on the Nasdaq.

☆ Stocks making the biggest moves midday: Wynn Resorts, Microsoft, Honeywell, Salesforce and more
▼ + stars: | 2023-01-04 | by ( Michelle Fox | ) www.cnbc.com time to read: +5 min

The Wynn Resorts logo stands illuminated as people sit by the fountain at the Wynn Macau casino resort in Macau, China, on Tuesday, July 24, 2018. Check out the companies making the biggest moves midday:Wynn Resorts — The casino operator's stock jumped nearly 7%, building on its solid start to 2023. Salesforce — Shares of the cloud-based software company jumped more than 3% after Salesforce announced that it is cutting 10% of its personnel and reducing some office space as part of a restructuring plan. Celanese — The global chemical and specialty materials company jumped more than 6% after being upgraded by RBC Capital Markets to outperform from sector perform. The firm cited the solar company stock's "steep drop from the initial euphoria created by the Inflation Reduction Act."

☆ Stocks making the biggest moves premarket: General Electric, Salesforce, Alibaba and more
▼ + stars: | 2023-01-04 | by ( Tanaya Macheel | ) www.cnbc.com time to read: +3 min

Check out the companies making headlines in premarket trading. Shares of GE were up about 2% in premarket trading. Microsoft — Microsoft shares dropped about 2% after UBS downgraded the tech giant to neutral from buy. Merck — Merck's stock rose about 1.7% after being upgraded to buy from neutral by Bank of America. Honeywell — Shares of Honeywell slipped 1.8% in the premarket after being double downgraded by UBS to sell from buy.

☆ General Electric Set to Spin Off Health Unit—Putting Focus Back on Power Division
▼ + stars: | 2023-01-02 | by ( Thomas Gryta | ) www.wsj.com time to read: 1 min

General Electric’s wind and gas turbine businesses are expected to be combined with other GE energy businesses into GE Vernova, to split off in early 2024. General Electric Co. will start 2023 by splitting off its healthcare unit, completing a key step in the slow-motion breakup of the industrial giant. For the rest of the year it will face questions about the next big step: shedding its power businesses. GE HealthCare Technologies Inc. will start trading this week, leaving the once-sprawling conglomerate with three divisions: jet engines, natural gas-powered turbines and wind turbines. The gas and wind turbines are expected to be combined with other GE energy businesses into a new company called GE Vernova that will split off in early 2024.

☆ Stocks making the biggest moves premarket: Tesla, Cal-Maine, Southwest and others
▼ + stars: | 2022-12-29 | by ( Peter Schacknow | ) www.cnbc.com time to read: +2 min

Cal-Maine Foods (CALM) – Cal-Maine slid 4.9% in premarket trading after its quarterly earnings came in below Wall Street forecasts. General Electric (GE) – GE spin-off GE HealthCare Technologies will join the S&P 500 when it begins trading as a separate public company on Jan. 4. Vornado will replace logistics company RXO (RXO), which will move to the S&P SmallCap 600. GE HealthCare — trading on a when-issued basis — rose 1% in the premarket, while Vornado was marginally lower and RXO jumped 3.3%. Apple (AAPL) – Apple is up 1% in premarket trading after closing Wednesday at a 1-1/2 year low.

Search resuls for: "GE Healthcare Technologies"

25 mentions found